Tennessee SB1790 amends state law to ensure insurers do not disadvantage non-opioid pain medications in their coverage.
Tennessee SB1790 amends state law to require insurers to ensure that non-opioid medications are not disadvantaged in their coverage compared to opioid medications. This applies to drugs approved by the FDA for at least nine months. The act mandates that insurers maintain their preferred drug lists (PDL) without disadvantaging non-opioid medications. The changes take effect on January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.